UK markets closed
NIKKEI 225
27,685.47 -8.18 (-0.03%) HANG SENG
21,298.70 +76.54 (+0.36%) CRUDE OIL
77.46 +3.35 (+4.52%) GOLD FUTURES
1,884.30 +4.80 (+0.26%) DOW
34,156.69 +265.67 (+0.78%) BTC-GBP
19,260.96 +116.92 (+0.61%)
Organon & Co. (0A9W.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 06:01PM GMT
| Previous close | 31.47 |
| Open | 31.60 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 31.38 - 31.60 |
| 52-week range | 31.38 - 31.60 |
| Volume | |
| Avg. volume | N/A |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 16 Feb 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Business Wire
Organon To Report Fourth Quarter and Full Year Results and Host Conference Call on February 16, 2023
JERSEY CITY, N.J., February 06, 2023--Organon (NYSE: OGN), a global women’s healthcare company will release its fourth quarter and full year 2022 financial results on February 16, 2023, prior to the company’s webcast and conference call scheduled for 8:30 a.m. EST.
- Zacks
Will Organon (OGN) Beat Estimates Again in Its Next Earnings Report?
Organon (OGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
- Business Wire
Organon Makes Strategic Investment in Claria Medical to Support Development of Investigational Medical Device for Minimally Invasive Hysterectomy
JERSEY CITY, N.J., January 05, 2023--Organon Makes Strategic Investment in Claria Medical to Support Development of Investigational Medical Device for Minimally Invasive Hysterectomy
© 2023 Yahoo. All rights reserved.
